Recent advances in thiazole-based derivatives targeting diverse anti-inflammatory pathways
Abstract
Various acute and chronic disorders, such as cancer, neurological diseases, cardiovascular disorders, and arthritis, are linked to inflammation. However, the long-term utilization of the available anti-inflammatory medications is frequently restricted by side effects and inadequate selectivity, emphasizing the need for safer and more effective therapeutic agents. A thiazole scaffold emerged as a unique framework in medicinal chemistry owing to its prominent biological effectiveness and favorable pharmacokinetic characteristics. Recently, substantial interest has been gained by various thiazole-based derivatives as potential anti-inflammatory drugs. The thiazole-containing derivatives have exerted prominent anti-inflammatory effects via a variety of mechanisms, such as suppression of COX and LOX enzymes, inhibition of pro-inflammatory cytokines such as TNF-α and IL-6, as well as the impediment of the significant inflammatory signaling pathways. It has been demonstrated that the substitution patterns and hybridization of the thiazole scaffold with other bioactive pharmacophores led to the improvement of the anti-inflammatory effectiveness and selectivity. The current review highlights the thiazole-based anti-inflammatory derivatives as promising candidates, encompassing publications from 2020 to 2025 for the discovery of innovative anti-inflammatory therapies by focusing on varied synthetic routes, structure-activity relationships, and mechanistic insights, besides their…
Read the paper
Related studies
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
- Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease
- Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience
- Celecoxib or naproxen treatment does not benefit depressive symptoms in persons aged 70 and over: findings from a randomized controlled trial
- Comparative Clinical Effectiveness of Nonsurgical Treatment Methods in Patients With Lumbar Spinal Stenosis: A Randomized Clinical Trial
- Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.